Antares Pharma Inc

Type: Company
Name: Antares Pharma Inc
Nationality: United States
Web Address: http://www.antarespharma.com/
First reported Oct 20 2014 - Updated Oct 20 2014 - 2 reports

Advanced Cell Technology Appoints As SVP Of Business Development & Chief Commercial Officer

Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced the appointment of LeRoux Jooste to the newly created position of Senior Vice President of Business Development and Chief Commercial Officer. ... [Published BioSpace - Oct 20 2014]
First reported Oct 20 2014 - Updated Oct 20 2014 - 1 reports

New commercial chief at Advanced Cell Tech

News EditorAdvanced Cell Technology (OTCQB:ACTC -1.8%) appoints LeRoux Jooste as SVP of Business Development and Chief Commercial Officer. He joins the firm from Antares Pharma where he was SVP and GM, Pharmaceuticals.Sent to 6,525 people who get email ... [Published Seeking Alpha - Oct 20 2014]
First reported Oct 12 2014 - Updated Oct 12 2014 - 2 reports

Update: Antares Pharma Looks To Improve Intellectual Property

By Mark Chapman :In a previous article , I indicated that the uncertainty of Antares Pharma (NASDAQ: ATRS ) intellectual property (IP) was a likely concern for many investors, thus aiding in the steep sell-off of the company's stock. The strength of Antares ... [Published BioPortfolio - Oct 12 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

Advanced Cell Technology's Turnaround Has Near-Term Catalysts

By BiOCell :Advanced Cell Technology ( OTCQB:ACTC ) has made great strides, especially in the last several months. When Paul Wotton decided to leave a secure high paying CEO position at Antares Pharma to come aboard a financially strapped company with ... [Published BioPortfolio - Oct 07 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Auto-Injector

By Ali Yasar :Antares Pharma (NASDAQ: ATRS ) developed various injection technologies, which include disposable pressure-assisted auto injectors, multi-use pen injectors, and reusable needle-free injectors. Its Vibex injector platform is specifically ... [Published BioPortfolio - Sep 30 2014]
First reported Sep 24 2014 - Updated Sep 25 2014 - 1 reports

Interesting ATRS Call Options For May 2015

Investors in Antares Pharma Inc. (ATRS) saw new options become available this week, for the May 2015 expiration.. ... [Published Chicago Daily Herald - Sep 24 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. The Company also announced that a retained search has begun to fill the position ... [Published FierceBiotech - Sep 19 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 4 reports

Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer

EWING, N.J.--(BUSINESS WIRE)-- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. The Company also announced that a retained search has begun to fill the position ... [Published Investor's Business Daily - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 2 reports

Insider Buying: Antares Pharma CEO Acquires 9,000 Shares of Stock (ATRS)

Antares Pharma (NASDAQ:ATRS) CEO Eamonn P. Hobbs bought 9,000 shares of Antares Pharma stock on the open market in a transaction dated Wednesday, September 10th. The stock was purchased at an average price of $2.20 per share, for a total transaction of ... [Published American Banking News - Sep 12 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 3 reports

Antares Pharma to Participate at the Morgan Stanley Healthcare Conference

EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial Officer and President of the Parenteral Products Group, will ... [Published EON Science - Sep 03 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 3 reports

Antares Pharma to Host Second Quarter 2014 Operating and Financial Results Conference Call

EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its second quarter 2014 financial results before the market opens on Thursday, August 7, 2014, and host a conference call shortly thereafter ... [Published EON Science - Jul 31 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 3 reports

Antares Pharma Announces First Patient Dosed in Phase 3 QuickShot Study Evaluating Testosterone-Deficient Adult Males

EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the first patient has been dosed in a double-blind, multiple-dose, phase 3 study to evaluate the efficacy and safety of QuickShot® Testosterone (QS T) administered ... [Published EON Science - Jul 22 2014]

Quotes

Original Article: NEXT ARTICLE More From BioPortfolio on "Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Auto-Injector"
...Antares hasn't given any guidance, but they stated "we believe that a once weekly, convenient, precise quick-to-administer subcutaneous dose of testosterone will become the choice route of administration" during their Q1-2014 conference call
"I'm excited to assume the newly created role of Chief Operating Officer," stated Robert F Apple. "Antares Pharma has grown from an innovator of novel technologies to a combination drug/device commercial company in the eight plus years I've been here. I believe that the combination of my commercial, technical and financial backgrounds will provide a great source of experience as we move Antares toward becoming a fully integrated pharmaceutical company."

More Content

All (67) | News (22) | Reports (0) | Blogs (39) | Audio/Video (0) | Fact Sheets (0) | Press Releases (6)
sort by: Date | Relevance
Needle-Free Delivery: Technology and Market For... [Published Scottrade - Oct 21 2014]
Advanced Cell Technology Appoints As SVP Of Bus... [Published BioSpace - Oct 20 2014]
New commercial chief at Advanced Cell Tech [Published Seeking Alpha - Oct 20 2014]
Advanced Cell Technology Appoints LeRoux Jooste... [Published Business Wire Health News - Oct 20 2014]
Update: Antares Pharma Looks To Improve Intelle... [Published BioPortfolio - Oct 12 2014]
Update: Antares Pharma Looks To Improve Intelle... [Published Seeking Alpha - Oct 12 2014]
Advanced Cell Technology's Turnaround Has Near-... [Published BioPortfolio - Oct 07 2014]
Comparative Analysis Reveals Undervalued Asset ... [Published BioPortfolio - Sep 30 2014]
Comparative Analysis Reveals Undervalued Asset ... [Published Seeking Alpha - Sep 29 2014]
Interesting ATRS Call Options For May 2015 [Published Chicago Daily Herald - Sep 24 2014]
Analysts View on Health Care Equipment and Supp... [Published Financial Services - Sep 24 2014]
Leasing of flex industrial space picks up locally [Published Finance & Commerce - Sep 24 2014]
Unilife: A Medical Device Company Poised For Ma... [Published Seeking Alpha - Sep 19 2014]
Antares Pharma Announces Promotion of Robert F.... [Published FierceBiotech - Sep 19 2014]
Antares Pharma CEO Eamonn P. Hobbs Purchases 9,... [Published American Banking News - Sep 16 2014]
Antares Pharma Announces Promotion of Robert F.... [Published Investor's Business Daily - Sep 15 2014]
Antares Pharma Promotes Robert Apple To COO - Q... [Published RTTNews.com - Sep 15 2014]
Antares Pharma Announces Promotion of Robert F.... [Published Crawford Financial Planning - Sep 15 2014]
Antares Pharma Announces Promotion of Robert F.... [Published Business Wire Health News - Sep 15 2014]
Insider Buying: Antares Pharma CEO Acquires 9,0... [Published American Banking News - Sep 12 2014]
Insider Buying: Antares Pharma CEO Buys 9,000 S... [Published American Banking News - Sep 12 2014]
Antares Pharma: Significant Value Or Value Trap? [Published BioPortfolio - Sep 12 2014]
Antares Pharma: Significant Value Or Value Trap? [Published Seeking Alpha - Sep 12 2014]
Antares Pharma to Participate at the Morgan Sta... [Published EON Science - Sep 03 2014]
Antares Pharma to Participate at the Morgan Sta... [Published Business Wire Science: Science News - Sep 03 2014]
Antares Pharma to Participate at the Morgan Sta... [Published Business Wire Health News - Sep 03 2014]
5 Breakout Stocks Under $10 Set to Soar [Published The Street Latest - Aug 28 2014]
Health Care Equipment and Supplies Equities Scr... [Published Financial Services - Aug 18 2014]
Global Transdermal Drug Delivery Market 2014-20... [Published PR Newswire: General Business - Aug 07 2014]
Antares Pharma Reports Second Quarter 2014 Oper... [Published Business Wire Health News - Aug 07 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Advanced Cell Technology Appoints LeRoux Jooste... [Published Business Wire Health News - Oct 20 2014]
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today announced the appointment of LeRoux Jooste to the newly created position of Senior Vice President of Business ...
Antares Pharma Announces Promotion of Robert F.... [Published Business Wire Health News - Sep 15 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. The Company also announced that a retained search has begun to fill the position ...
Antares Pharma to Participate at the Morgan Sta... [Published EON Science - Sep 03 2014]
EWING, N.J.--(EON: Enhanced Online News)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial Officer and President of the Parenteral Products Group, will ...
Antares Pharma to Participate at the Morgan Sta... [Published Business Wire Science: Science News - Sep 03 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial Officer and President of the Parenteral Products Group, will participate ...
Antares Pharma to Participate at the Morgan Sta... [Published Business Wire Health News - Sep 03 2014]
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Eamonn P. Hobbs, President and Chief Executive Officer and Robert F. Apple, Chief Financial Officer and President of the Parenteral Products Group, will participate ...
1 2 3 4 5 6 7 8

Press Releases

sort by: Date | Relevance
Analysts View on Health Care Equipment and Supp... [Published Financial Services - Sep 24 2014]
Health Care Equipment and Supplies Equities Scr... [Published Financial Services - Aug 18 2014]
Global Transdermal Drug Delivery Market 2014-20... [Published GlobeNewswire: Advertising News - Aug 06 2014]
Pre-Market Pulse on Health Care Stocks -- Resea... [Published Financial Services - Jul 10 2014]
Pre-market Equity Watch on Health Care Equipmen... [Published Financial Services - Jun 19 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.